Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26F88JB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,249
Award facts
- Contract value 100% obligated
- $3,248.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/mL auto-injector on December 29, 2025, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. BENLYSTA (belimumab) is a monoclonal antibody used to treat systemic lupus erythematosus and other autoimmune conditions, with the auto-injector delivery mechanism providing patients with a convenient self-administration option.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical prime vendor contract authorizes the contractor to supply an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally, including services to the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to compete successfully in the federal pharmaceutical market and manage large-scale medical supply operations positions it as a critical vendor within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F88JB?
SPE2DR26F88JB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F88JB worth?
The government has obligated $3,249 on SPE2DR26F88JB.
Is contract SPE2DR26F88JB an order under another contract?
Yes. SPE2DR26F88JB is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88JB competed?
The extent of competition for SPE2DR26F88JB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award